Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 71 Show results per page	View Search Criteria \| Help With Results


1.		Phase II/III Chemotherapy and Hormone Therapy with ADR/VCR/DBD/PRED Followed by TMX/FXM/BLEO/HMM/MTX-CF for Metastatic Stage III/IV or Recurrent Breast Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				under 65								WCCC-CO-7711R NCI-D80-048-183

Last Modified: 5/15/2007


2.		Phase III Chemotherapy with Various Schedules of ADR for Soft Tissue and Bone Sarcoma and Mesothelioma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				14 to 75				NCI				EST-3377


3.		Phase III Chemotherapy with Adriamycin/Dibromodulcitol vs Adriamycin Alone for Resistant Advanced Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				postmenopausal								MAYO-793251 NCCTG-793251

Last Modified: 2/8/2008 First Published: 2/1/1995


4.		Phase III Randomized Study of Radiotherapy with DBD Radiosensitization Followed by DBD/BCNU vs Radiotherapy Alone for Anaplastic Astrocytomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				over 16								EORTC-26882 NCT00002620


5.		AC (ADR/CTX) Followed by CMFP (CTX/MTX/5-FU/PRED) or CMFP (DBD/MTX/5-FU/PRED) Both Alternating with AC for Metastatic Breast Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				under 70								NCI-D78-017-074

Last Modified: 8/9/2007


6.		L-ASP/PRED/VCR/ARA-C/ADR, DBD or CTX Plus Intrathecal Prophylactic MTX/CF for Marrow Relapse in Children with ALL/AUL LEUKEMIA

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				under 18				NCI				CCG-142A

Last Modified: 8/9/2007


7.		L-ASP/PRED/VCR/ARA-C/ADR, DBD OR CTX, Plus Intrathecal ARA-C/HC/MTX/CF for Marrow and CNS Relapse in Children with ALL/AUL

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				under 18				NCI				CCG-142B

Last Modified: 4/10/2007


8.		Phase III Induction with DAVTH (DBD/ADR/VCR/TMX/HAL) plus Randomized Maintenance for Metastatic or Recurrent Breast Cancer in Men and Women

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified				NCI				EST-2181 EST-2181

Last Modified: 4/10/2007


9.		Phase III Chemotherapy with DAVcH (DBD/ADR/VCR/HAL) vs TsAVbH (Thiotepa/ADR/VBL/HAL) for Disseminated or Recurrent Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified				NCI				EST-6181

Last Modified: 11/18/2005


10.		Phase III Randomized Study of Chemohormonal Therapy with DATH (DBD/DOX/TMX/FXM) vs D(DHAD)TH (DBD/DHAD/TMX/FXM) in Patients with Previously Treated Metastatic Breast Cancer Who Have Had No Prior Exposure to Doxorubicin

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified				NCI				EST-7181 EST-7181

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute